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ABSTRACT
Aims: The Internet has marked a revolution in the supply of illegal drugs, while at the same time, new
types of illegal and semilegal drugs increasingly are becoming available. In order to deepen our under-
standing of the demand and supply of these new drugs on the Internet, this study focuses on the
demographic characteristics, methods and preferences of people who purchase ‘lifestyle drugs’ through
the surface web.
Methods: Data were obtained through the following two surveys: a prevalence study of 50,848 Dutch
respondents and an in-depth study of 153 people who have purchased lifestyle drugs online.
Findings: At least 10.2% of the Dutch adult population has bought medicines online; the majority
being lifestyle drugs (5.2%). In addition, an estimated 1.6% of the Dutch population has purchased
medicines illicitly, with the majority of products concerning lifestyle drugs (0.9%). Illicit lifestyle drugs
are primarily purchased through e-commerce sites and online pharmacies, and users report high satis-
faction rates.
Conclusion: Purchasing lifestyle drugs is characterised by specific online dynamics, as the drugs are
often openly accessible and the boundaries between legal and illegal sale blurred. As new types of
drugs become available, it is important to further monitor customers’ preferences and experiences.
ARTICLE HISTORY
Received 19 March 2017
Revised 15 August 2017
Accepted 17 August 2017
KEYWORDS
Lifestyle drugs; counterfeit
medicines; human
enhancement drugs; online
markets; surface web; dark
web; online pharmacies
Introduction
The speed with which the Internet is transforming illicit drug
markets poses a major challenge to law enforcement, public
health, research and monitoring agencies (EMCDDA, 2016).
People are no longer restricted to local drug dealers; the
Internet enables consumers easily to exchange information
and purchase illegal drugs from all around the world.
Customers use the dark web for purchasing traditional drugs
(Van Hout & Bingham, 2013), while the surface web is pre-
ferred for lifestyle drugs (Di Nicola et al., 2015) and novel psy-
choactive substances (NPSs; see EMCDDA, 2016; Wadsworth,
Drummond, & Deluca, 2017). The benefit of the Internet com-
pared to traditional street-level transactions is that the iden-
tity of both buyers and sellers stays more hidden and that
users have the possibility of accessing a broader range of
harm reduction advice and product reviews (Aldridge &
Decary-Hetu, 2016; Van Hout & Bingham, 2013). As a result,
and in combination with supply side dynamics that put
downward pressure on consumer prices (Koenraadt, forth-
coming), the online marketing and sales of drugs has
increased substantially. And, concomitant with rapid changes
in the ways people obtain illegal drugs in the current decade,
a wide range of drug-related health problems have been
associated with new types of illegal and semilegal drugs
whose purchase is facilitated by the Internet (Khaled et al.,
2016; Venhuis et al., 2011). Lifestyle drugs, novel psychoactive
substances (NPSs) and precursor chemicals are central charac-
ters in this story (EMCDDA, 2016). In short, the range and
nature of drug markets online are expanding.
A particular concern is the online availability of illicit life-
style drugs that lie at the intersection of legal and illegal
drug markets. In the literature, a variety of terms are often
used interchangeably to describe drugs used for lifestyle and
well-being purposes and/or to enhance performance and
image. While some use the terms ‘lifestyle drugs’ or ‘human
enhancement drugs’, others prefer ‘lifestyle medicine’ or 'per-
formance and image enhancing drugs'. In this article, the
term ‘lifestyle drugs’ is used and defined as drugs that are
consumed in order to improve one’s lifestyle, health or
beauty, which places their use on the borderline between a
health need and lifestyle wish (Gilbert, Walley, & New, 2000;
Rahman, Gupta, Sukhlecha, & Khunte, 2010). Medicines like
Viagra to treat erectile dysfunction are included, as is Orlistat
to lose weight or cognitive enhancers such as Ritalin to boost
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concentration. While most lifestyle drugs are medicines avail-
able through official sources for particular purposes and
requiring a prescription, they are also taken for non-author-
ised reasons to improve someone’s life, physical function or
appearance, as opposed to a medicine which is taken specif-
ically to cure or manage an illness. For all of these reasons,
lifestyle drugs may therefore be considered a specific subclass
of medicine. In addition, some scholars also include a large
variety of semilegal medicines, mainly adulterated food sup-
plements with experimental chemical substances, in their def-
inition of lifestyle drugs. Because the analogues are unknown,
these products generally do not (yet) fall under medicine or
food legislation of national countries (Venhuis et al., 2009,
2011). These products and their purchasers are excluded from
the current study. In order to understand the expanding
boundaries of drug markets, this article focuses on the preva-
lence and dynamics of purchasing medicines online and legal
and illegal lifestyle drugs in particular.
Lifestyle drugs can be sold both legally and illegally
online. More and more people purchase medicines online
due to either the ease and convenience of this platform or
because of the shame they sometimes experience during in-
person transactions (Di Nicola et al., 2015; Intomart, 2009;
2012; Koenraadt & de Haan, 2016). This includes legitimate
online pharmacies offer both over-the-counter and prescrip-
tion-only medicines. At the same time, a growing illicit mar-
ket exists in which counterfeit medicines, stolen lifestyle
drugs or unlicensed generics are sold (Venhuis et al., 2011).
Indeed, recent years have witnessed growing Internet sales of
lifestyle drugs, and the literature points to illicit online phar-
macies as an important source of distribution (Cohen, Collins,
Darkes, & Gwartney, 2007; Cordaro, Lombardo, & Cosentino,
2011; De Hon & van Kleij, 2005; Gezondheidsraad, 2010;
Scammell & Bo, 2016). For example, this may occur through
illegal or fake pharmacies that might give the impression of
propriety with a professional presentation, images of doctors
in white coats and apparently genuine diagnostic tests (Di
Nicola et al., 2015). Websites that hawk illicit medicines may
convince consumers into believing that they can order all
types of medicines, and that they are all legal medicines.
On the Internet, there are two distinct sources to purchase
all sorts of drugs. One is the dark web, with cryptomarkets such
as Silk Road drawing much attention, and the other being the
freely accessible surface web, which can be accessed through
search engines like Google or Yahoo. The substances marketed
and sold on the surface web are mainly non-controlled sub-
stances or substances, including lifestyle drugs, for which legal
controls differ between countries and jurisdictions (EMCDDA,
2016). Due to the blurring boundaries between the legitimate
and illegitimate sale of these substances, it is particularly diffi-
cult to regulate the online lifestyle drugs market (Hall &
Antonopoulos, 2016; Paoli & Donati, 2014; Van de Ven, 2015).
For example, lifestyle drugs in the Netherlands are controlled
as different classes and schedules of drugs, under different
forms of legislation (Economic Offences Act (2001); Medicine
Act (1963); Opium Law (1976)), with different responsible
bodies (e.g. police and the Health Care Inspectorate).
Disharmony among regulations across countries is even more
problematic. As such, national regulation is often ineffective
and poorly equipped to deal with the international character of
the online trade (Evans-Brown, McVeigh, Perkins, & Bellis, 2012).
The choice to purchase medicines on licit or illicit markets
is often associated with the purpose of consumption. First of
all, lifestyle drugs are used to treat afflictions, such as bald-
ness, erectile dysfunction or acne and are considered to treat
conditions on the boundary of a medical need and a lifestyle
wish (Gilbert et al., 2000). Consumers who are eligible to
make purchases in the legal market may nonetheless be
deceived into purchasing illicit medicines, for example by an
illegal online pharmacy. However, it is abundantly clear that a
large share of consumers seek lifestyle drugs for reasons doc-
tors do not recognise as prescription worthy, for instance, to
enhance bodily, cognitive and sexual attributes and abilities
(Evans-Brown et al., 2012; McVeigh, Evans-Brown, & Bellis,
2012). The illicit market, either online or offline, is the only
option for these customers to obtain lifestyle drugs. This
group may include bodybuilders who use steroids to increase
muscle mass (Monaghan, 2001; Paoli & Donati, 2014; van de
Ven, 2015), students who use cognitive enhancers such as
Ritalin for better study results (Mazanov, Dunn, Connor, &
Fielding, 2013) or consumers who take sexual enhancers (e.g.
Viagra) during nightlife (Intomart, 2009, 2012; Koenraadt,
2015; Koenraadt & de Haan, 2016).
The ease with which illicit lifestyle drugs can be distrib-
uted and accessed online has resulted in a growing public
health and criminal justice challenge (Evans-Brown et al.,
2012). As such, understanding consumers’ purchasing behav-
iour and perceptions when purchasing lifestyle drugs online
is key to successfully design and implement public health
interventions or law enforcement strategies. To date, studies
on the role of the Internet have highlighted online sale of
illegal drugs via the dark web (i.e. Barratt, Ferris, & Winstock,
2014; Buxton & Bingham, 2015; Van Hout & Bingham, 2013)
or the use of cryptomarkets for trading drugs (Aldridge &
Decary-Hetu, 2016; Martin, 2014). Only a few studies have
examined the sale of NPSs (EMCDDA, 2016; Wadsworth et al.,
2017) or the availability of lifestyle drugs via the surface web
(Lavorgna, 2015; Van Hout, 2014; Van Hout & Brennan, 2014).
These studies show that, while some consumers are attracted
to the dark web’s famously anonymous environment, those
who are in legal grey rather than black areas are hindered by
the dark web’s requirement of specific software to gain
access, which increases the appeal of surface platforms. This
literature generally refers to the Internet pharmacies as the
main surface web source for obtaining lifestyle drugs (Di
Nicola et al., 2015; Di Giorgio, 2011), although other types of
websites have been identified as well (Van de Ven, 2015).
On the surface web, legitimate and illegitimate sales inter-
mingle and it is difficult for consumers to estimate the reliabil-
ity of websites that either are or pose as legitimate online
pharmacies (Di Nicola et al., 2015; Lavorgna, 2015). As such, it
is likely that the prevalence, demographic characteristics,
motives and decision-making process of consumers on the
surface web are different from those who purchase fully illegal
drugs on the deep web. Because the nature and range of
drugs has changed rapidly during the past decade, it is plaus-
ible to imagine that the nature and range of consumers has
expanded as well. Thus, it is important to augment existing
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information on drug markets with new data that incorporates
both new types of drugs, such as illicit lifestyle drugs that are
easily accessible on the surface web, and their consumers.
In this article, we examine the purchasers of licit and illicit
medicines, and in particular, Dutch purchasers of illicit life-
style drugs through surface websites. We specifically focus on
lifestyle drugs as medicines, as opposed to (herbal) supple-
ments (e.g. protein supplements, creatine and vitamins).
These include prescription lifestyle drugs and over the coun-
ter medicines that can be purchased in pharmacies. In this
study, we speak of illicit lifestyle drugs, which include all
medicines that are not produced, sold and/or purchased
according to Dutch or international regulations. As such, for
example, we include in this article illicit weight loss drugs
such as Slimex (which is banned from the market and thus all
purchases are illegal) or Orlistat (when obtained outside the
legal supply chain and usually without a doctor’s prescrip-
tion). Because of difficulties filtering out purchasers of illicit
medicines only, we use data regarding purchasers of both
legal and seemingly illicit medicines online.
The current study and its findings are part of a larger pro-
ject on the online purchase of medicines in the Netherlands.
The focus of the current paper is twofold. First, we present
data on the prevalence and demographic characteristics of
online buyers of medicines in general, with particular attention
given to the purchasing of illicit lifestyle drugs. Second, we
offer an in-depth analysis of the motives and methods for the
online purchase of two types of lifestyle drugs: illicit weight-
loss medicines and erectile dysfunction medicines. As our ana-
lysis will demonstrate, products from these two categories are
among the most popular illicit lifestyle drugs bought online.
Methods
As part of a larger study on the market for illicit medicines,
survey data were gathered from online buyers of medicines
in the Netherlands. Respondents for the survey were mem-
bers of a panel recruited by the market research agency
Intomart Gfk in the Netherlands. Utrecht University’s Faculty
of Law, Economics and Government granted ethical approval
for the study.
The presented data emanate from two surveys: (I) a preva-
lence study (N¼ 50,848) to estimate the occurrence of pur-
chasing medicines online, and (II) an in-depth survey
(N¼ 447) among respondents who indicated that they had
purchased illicit medicines (including lifestyle drugs) via sur-
face websites. The in-depth survey contains questions on
motives for purchasing online, risk perception and
satisfaction.
Prevalence study
In order to estimate the proportion of Dutch citizens who pur-
chase regular medicines online, those who purchase illicit med-
icines online or those considering whether to purchase these
products online in the near future, a prevalence study was con-
ducted. The prevalence study took place in August 2015 and
included 50,848 respondents aged between 18 and 90 years
old in the Netherlands. The respondents are on a panel of the
market research agency Intomart, from which they receive
monthly requests to participate in computer-administered sur-
veys. Respondents included both individuals who had ordered
medicines online, including lifestyle drugs, and those who had
not. Although the panel itself is not a fully representative
reflection of the Dutch population, we were able to control for
age, gender, education and region and thus generate repre-
sentative estimates (see section on data analysis).
Four questions were asked of respondents: (I) what types of
medicines were purchased on the Internet; (II) what types of
medicines were purchased through unlicensed sources outside
the Internet; (III) whether the medicines were purchased with
a doctor’s prescription; and (IV) whether the medicines are offi-
cially available by prescription in the Netherlands. This com-
bination of questions enables us to make a general distinction
between online purchases of illicit medicines (measured as
prescription medicines purchased without a prescription and
medicines not available in the Netherlands) and seemingly
legitimate online purchases of medicines (obtained with a pre-
scription, or over-the-counter medicine).
In-depth survey
More detailed information about purchasing medicines online
is based on an in-depth questionnaire among 447 respond-
ents of which 153 respondents indicated that they had pur-
chased weight loss drugs and sexual enhancers online. Data
regarding these 153 are presented and analysed below. The
447 respondents of the in-depth survey were selected out of
a first panel of 56,700 respondents1. Of these, 1800 indicated
that (1) they had ever purchased medicines online, and (2)
they had purchased prescription drugs without a prescription.
447 respondents were selected from the 1800 participants
who fulfilled the selection criteria. In April 2015, the 447
respondents completed an extended computer-based ques-
tionnaire about their online purchase of illicit medicine.
The in-depth survey consisted of 60 questions divided into
various themes, such as purchasing behaviour, satisfaction,
motivations and risk perception. Questions focussed on the
specific type of medicines they purchased most regularly
online. The themes and the order of the questions were
partly based on previous Intomart surveys on purchasing
medicines online (2009, 2012). Although the primary focus
was on illicit or unofficial medicines, words such as ‘illicit’ or
‘illegal’ were omitted from the survey, in order to avoid deter-
ring participants, misreporting and social desirability bias.
Open and closed, sensitive and non-sensitive, long and short
questions were alternated.
Data analysis
The panel of the prevalence study among 50,848 respondents
(mean age: 53.6, std. dev. 14.6; 47% male, 53% female) did
not portray a fully representative sample of the Dutch popu-
lation. However, demographic information (gender, age,
region, education) on all respondents was made available
and compared with the general demographics of the Dutch
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population. Therefore, with the use of inverse probability
weights, representative estimates were made of the preva-
lence and profile of Dutch adult purchasers buying medicines
online. As such, we were able to control for these four demo-
graphic variables using the weight variable that has been
linked to the Dutch population by research agency Intomart.
In this study, we identified ‘weight-loss drugs’, ‘sexual
enhancers’, ‘birth control’, ‘quit smoking medication’ and
‘muscle drugs’ as lifestyle drugs. We focus solely on lifestyle
drugs as (prescription) medicines, and exclude lifestyle sup-
plements. For this article’s in-depth analysis, we identified
153 respondents from the in-depth survey who had pur-
chased the two most popular illicit lifestyle drugs online:
weight-loss drugs (N¼ 70) including Orlistat and Slimex, and
sexual enhancers (N¼ 88) including Viagra and Kamagra.
Data from both surveys have been analysed through the soft-
ware programmes SPSS, version 22 (Armonk, NY) and Stata,
version 14 (College Station, TX).
Limitations
The prevalence study of online medicine purchases provides
innovative information on the occurrence and demographic
characteristics of purchasers of lifestyle drugs and other types
of medicines. However, the use of survey questions to meas-
ure the prevalence of purchasing illicit medicines and lifestyle
drugs is associated with several methodological limitations.
First, it is difficult to identify and select purchasers of illicit
medicines. For example, it could be that purchasers did not
realise the website sold counterfeit or otherwise illegal prod-
ucts. It is therefore likely that the prevalence study underesti-
mates the number of illicit lifestyle drug purchasers in the
Netherlands. On the contrary, respondents might have pur-
chased medicines that, unbeknownst to them, were perfectly
legal. Many websites that offer illegal medicines offer legitim-
ate ones as well. In relation to this, medicines that have been
banned in the Netherlands may have been purchased in
accordance with other countries’ laws; to this extent, we may
have overestimated the prevalence of illicit medicines. For
these reasons, we chose to include prevalence of both legal
and illegal medicines. The selection of respondents purchas-
ing illicit medicines could be improved in further studies by
also asking prevalence study respondents about specific med-
icines, instead of using a ‘general medicine class’ they pur-
chased (e.g. ‘Viagra’ as opposed to ‘sexual enhancers’).
Second, the respondents sorted by medicine type are not
fully representative and further research is needed in order to
gain more knowledge on the differentiated types of (illicit)
medicines and lifestyle drugs. In the prevalence study, we
defined our categories based on the drugs purchased and
not on the motivations that the purchasers bought it. At the
same time, in-depth study questions focussed on the types of
medicines that respondents had purchased most often online.
Whereas the results of the in-depth study on purchasers of
sexual enhancers and weight loss drugs are thus based on a
small sample, they are meant as an important indication for
further research on the demand and supply of different types
of illicit medicines. Third and finally, younger purchasers of
illicit medicines and lifestyle drugs are excluded from the sur-
vey, as the panel consists of respondents aged 18 years and
up. Young purchasers are an important target group for life-
style and human enhancement drugs, and further research
therefore must include young respondents as well.
Results
Overall profile of online buyers of medicines and
lifestyle drugs
Out of the 50,848 respondents, a total of 5165 respondents
between the ages of 18 and 90 stated that they had ever
purchased any type of medicine and/or lifestyle drug online.
This includes drugs available by prescription or over the
counter and includes both legal and illegal drugs. Using
Intomart’s inverse weighting process, we estimate that at
least 10.2% of the Dutch population buys or has bought
some type of medicine online. Columns 1 and 2 of Table 1
present the frequencies and percentages of online purchasers
of different types of medicines and lifestyle drugs. Painkillers
are the leading online purchases (31.8% of all online medical
purchases), followed by weight-loss drugs (27.0%), sedatives
and tranquillisers (14.2%) and sexual enhancers (14.0%).
The remaining 31.2% of online purchases are of a mixture of
other types of medicine. A total of 2655 respondents
Table 1. Types of medicine purchased online (N¼ 50,848).
All medicines purchased online Illicit medicines purchased online
(1)
n
(2)
Percentage of all medicines
purchased online
(3)
n
(4)
Percentage of all illicit medicines
purchased online
Painkillers 1640 31.8% 210 25.4%
Weight loss drugs 1397 27.0% 200 24.1%
Sedatives and tranquillisers 733 14.2% 157 18.9%
Sexual enhancers 723 14.0% 232 28.0%
Birth control 669 13.0% 87 10.5%
Quit smoking medication 387 7.5% 101 12.3%
Muscle drugs 334 6.5% 89 10.7%
Antibiotics 319 6.2% 100 12.1%
Antidepressants 274 5.3% 90 10.9%
ADHD medicines 267 5.2% 90 10.8%
Antiviral medicines 265 5.1% 90 10.9%
Other 1612 31.2% 220 26.6%
Some of these respondents reported that they purchased more than one variety of medicine. Therefore, columns (1) and (3) sum to more
than the n-number of respondents, and columns (2) and (4) sum to more than 100%.
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between the ages of 18 and 82 purchased drugs of one or
more of the lifestyle types: weight loss drugs, sexual
enhancers, birth control, quit smoking medication and muscle
drugs. Using Intomart’s inverse weighting formula, we esti-
mate that 5.2% of the Dutch population has ever purchased
lifestyle drugs online.
The specific types and prevalence of illicit medicines that
are purchased online are presented in columns 3 and 4 of
Table 1. Sexual enhancers are the largest group of illicit medi-
cines purchased online (28.0% of all illicit medicines), fol-
lowed by painkillers (25.4%), weight-loss drugs (24.1%) and
sedatives and tranquillisers (18.9%). Other types of illicit med-
icines purchased online are anti-depressants (10.9%), ADHD
medication (10.8%) and muscle-enhancing drugs (10.7%).
Furthermore, out of the 50,848 respondents, a total of 828
between the ages of 18 and 84 reported that they had pur-
chased prescription medicines without the use of a prescrip-
tion or had purchased medicines not available in the
Netherlands. Data from the prevalence study therefore indi-
cate that an estimated 1.6% of the Dutch population have
bought illicit medicines online. Of these 828 respondents, 460
between age of 19 and 79 years old purchased some type of
illicit lifestyle drug, resulting in an estimated 0.9% of the
Dutch population that has purchased illicit lifestyle drugs.
With the demographic information available on all
respondents of the prevalence study, it is possible to draw a
profile of online purchasers of medicines in general. As pre-
sented in columns 1 and 2 of Table 2, there is no significant
gender difference in purchasing medicines online in general:
50.6% of buyers are male and 49.4% are female. However,
men tend to purchase a broader variety of medicines online.
Further, four kinds of substances are purchased predomin-
antly by men: two lifestyle drugs, namely sexual enhancers
(85.6% male) and muscle-enhancing drugs (82.9% male); anti-
depressants (77.3% male); and ADHD medication (77.2%
male). Weight-loss drugs are the only substances that women
buy more frequently than men (61.3% female). Interestingly,
it appears that, overall, men purchase illicit medicines signifi-
cantly more than women. Columns 3 and 4 of Table 2 illus-
trate that 64% of the purchasers of illicit medicines are men
and 36% are women. With the exception of weight-loss
drugs, more men than women purchase every type of drug
online. Illicit lifestyle drugs most often purchased by men are
again sexual enhancers (90% male), muscle-enhancing drugs
(88.6% male) and quit-smoking medication (82.4% male).
Table 3 presents the mean age of the online buyers per
class of medicine. The mean age of the online purchasers is
44.7 years of age (SD¼ 15.4). On average, purchasers of
online painkillers are among the oldest (44.3 y, SD¼ 15.7) and
purchasers of ADHD medicines are the youngest (32.4 y,
SD¼ 10.3). Furthermore, younger purchasers are more likely
to purchase multiple types of medicines at the same time
and are therefore counted multiple times for the average age
of separate medicines types. This explains why the overall
average age (44.7 and 44.5) is higher than the average age
per medicine type. In addition, purchasers of illicit painkillers
are again among the oldest (42.7 y, SD¼ 16.4), followed by
purchasers of the lifestyle drugs sexual enhancers (42 y,
SD¼ 15.3) and weight loss drugs (40.7 y, SD¼ 14.7).
Based on the first panel of 56,700 respondents, buyers
were selected for the in-depth study in which the motives
and methods to purchase medicines online are examined in
more detail. It is important to differentiate by drugs type, as
the motives for their consumption, the way to obtain them,
satisfaction rates and risk assessment may vary depending on
the substance being used. For the next section, we focus on
the two most popular lifestyle drugs purchased through the
surface web: illicit weight-loss drugs (hereafter: weight-loss
drugs) and illicit sexual enhancers (hereafter: sexual
enhancers). The motives, methods and satisfaction rates of
these respondents will be discussed.
Motives and risk assessment
Detailed information about the motives, methods and satis-
faction when purchasing lifestyle drugs online was provided
by the in-depth questionnaire (N¼ 447). Of these 447
respondents, 153 are relevant to the current article because
they reported having purchased weight-loss drugs (N¼ 70),
primarily including Slimex and Orlistat without a prescription
and/or sexual enhancers (N¼ 88), primarily including Viagra
and Kamagra without a prescription online. There are various
motivations that drive buyers to purchase these lifestyle
Table 2. Medicines by the gender of buyers (n¼ 5165).
Gender online
buyers all
medicines
Gender online
buyers illicit
medicines
(1)
Male
(2)
Female
(3)
Male
(4)
Female
Sexual enhancers 85.6% 14.4% 90% 10%
Antiviral medicines 84.2% 15.8% 92.2% 7.8%
Muscle drugs 82.9% 17.1% 88,6% 11.4%
Antidepressants 77.3% 22.7% 88.9% 11.1%
ADHD medicines 77.2% 22.8% 92.2% 7.8%
Antibiotics 76.8% 23.2% 83% 17%
Quit smoking medication 69.3% 30.7% 82.4% 17.6%
Painkillers 56.2% 43.8% 71.4% 28.6%
Sedatives and tranquillisers 55.5% 44.5% 69.2% 30.8%
Birth control 49% 51% 78.2% 21.8%
Weight loss drugs 38.7% 61.3% 51.5% 48.5%
Rest group 52% 48% 65.5% 34.5%
Total 50.6% 49.4% 64.1% 35.9%
Significant differences between male and female purchasers.
Table 3. Mean age of online buyers per medicine type (n¼ 5165).
Age online buyers all
medicines
Age online buyers
illicit medicines
Mean age
Standard
deviation Mean age
Standard
deviation
Painkillers 44.3 15.7 42.4 16.4
Sedatives and tranquillisers 40.4 15.7 39 15
Weight loss drugs 39.1 13.5 40.7 14.7
Antiviral medicines 36.3 12.5 31.7 12
Sexual enhancers 35.7 13.3 42 15.3
Antibiotics 35.3 13.6 34.2 13.6
Antidepressants 34.7 12.7 30.9 10.0
Quit smoking medication 34.6 11.1 36.6 13.8
Muscle drugs 34.0 11.8 31.5 11.5
Birth control 33.7 10.2 32.3 10.8
ADHD medicines 32.4 10.3 28.8 7.7
Rest group 42.8 15.8 44.3 16.7
Total 44.7 15.4 44.5 15.5
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drugs online. As presented in Figure 1, financial motives, con-
venience and home delivery are the most important factors
for the purchasers of both illicit weight-loss drugs and sexual
enhancers. Looking at the situation in more detail, a particu-
lar reason for purchasing sexual enhancers online is that 24%
of the buyers do not want to discuss this with their physician.
The main motivations for purchasing weight-loss drugs online
are convenience (43%) and home delivery (39%).
Generally, buyers rely on various characteristics by which
they determine the trustworthiness of the website they use.
The features are presented in Figure 2. After a respondent
had chosen to explore the Internet options for lifestyle drug
purchases, their choice of website was most strongly affected
by clear information about the vendor and lifestyle drugs
(43% and 42%), a clear overview of available lifestyle drugs
(35% and 25%), and reviews of others (26% and 44%).
Websites for purchasing online lifestyle drugs
Sexual enhancers and weight-loss drugs, as expected, are
being sold through so-called online pharmacies, in, respect-
ively, 22% and 17% of cases (Figure 3). However, the data
show that other vending websites appear to be used even
more frequently, including second-hand vending sites and
‘specialist websites’ that focus on the sale of particular life-
style drugs (47% and 38%, respectively). Respondents do not
list social media as an important online source (2% and 4%).
It is generally acknowledged that customers may face vari-
ous difficulties in their effort to determine the risks and qual-
ity of lifestyle drugs offered online. Nevertheless, findings
from this study indicate that respondents seem to be loyal
customers who often return to the same website. In particu-
lar, purchasers of sexual enhancers are most consistent in
returning to the same website, as 44% of the respondents
stated they always use the same website to purchase lifestyle
drugs (Figure 4). Purchasers of weight-loss drugs more often
differ in the website they choose (34%).
Satisfaction
In line with the finding that purchasers tend to return to the
same website for subsequent lifestyle drug purchases
(Figure 4), we find that buyers are generally satisfied with
their online purchase and the quality of these lifestyle drugs.
Figure 5 provides an overview of customers’ levels of satisfac-
tion with the information on and quality of lifestyle drugs.
Figure 1. Motivations for purchasing sexual enhancers (n¼ 88) and weight loss drugs (n¼ 70).
Figure 2. Reasons why buyers trust a website when purchasing sexual enhancers (n¼ 88) and weight loss drugs (n¼ 70).
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Overall, purchasers report to be satisfied or very satisfied with
information and drug quality.
Finally, we found that more than one-third of buyers
would recommend others to purchase lifestyle drugs online.
In total, 36% of purchasers of weight-loss drugs and 47% of
sexual enhancers would recommend purchasing (illicit) life-
style drugs online to others.
Discussion and conclusion
This article provides insights into the role of the Internet in
illicit lifestyle drug markets from a buyers’ perspective.
Although a growing body of research on online drug markets
is available, recent studies focus on purchasing drugs through
the dark web (Buxton & Bingham, 2015; Martin, 2014; Van
Hout & Bingham, 2013), or the supply of NPS via the surface
web (EMCDDA, 2016; Wadsworth et al., 2017). What makes
the market for lifestyle drugs unique is their open accessibil-
ity through the surface web, where all kinds of legitimate,
semilegitimate and illegitimate products intermingle
(EMCDDA, 2016; Walsh, 2011). In addition, few studies focus
on buyers, whose demographic characteristics, motives, ideas
and preferences have been unknown. The results of this
study provide a basis for further research on how the
Internet mediates the supply and demand of new illegal and
semi-legal drugs, more specifically lifestyle drugs.
General profile of online purchasers of medicines and
lifestyle drug users
Data from our prevalence study illustrate that an estimated
10.2% of the Dutch population between 18–90 years old pur-
chases or has ever purchased medicines online. This is a
slightly lower percentage than previous prevalence estimates.
For example, based on a web survey conducted in seven
European countries, Di Nicola et al. (2015) measured that
16% of the 874 online recruited respondents had at one time
purchased medicines online during their lives. A Sanofi study
among 5010 European citizens concluded a prevalence of
18% of respondents had at one time purchased medicines
Figure 3. Type of website used for purchasing sexual enhancers (n¼ 88) and weight loss drugs (n¼ 70).
Figure 4. Variety in the websites used for purchasing sexual enhancers (n¼ 88) and weight loss drugs (n¼ 70).
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online (Di Nicola et al., 2015). In the Netherlands, two studies
conducted by Intomart (2009, 2012) suggest that the propor-
tion of the Dutch population that has purchased medicines
online grew from 3% in 2009 to 13% in 2012. The current
study included only adult respondents, which may result in
lower estimates. Yet, our estimates rely on a large representa-
tive panel and use inverse probability weights and are there-
fore a robust indication of the proportion of the adult
population that purchases medicines via the Internet in the
Netherlands. The most online-purchased medicines are pain-
killers, sedatives, weight-loss drugs and sexual enhancers.
These medicines are high on the list of illicit medicines that
are most frequently purchased online: lifestyle drugs, and opi-
oid analgesics and psychotropic substances (Lavorgna, 2015).
An estimated 5.2% of the Dutch population between 18
and 82 years old has purchased lifestyle drugs through the
surface web.
In addition, contrary to the previous studies, this research
has made a first attempt to estimate the prevalence of
the population that purchases illicit medicines. As such, the
prevalence study indicates that an estimated 1.6% of the
population between 18–84 years old had at one time pur-
chased illicit medicines. Yet, as outlined, purchasers do not
always know they dealt with a legal or illegal supplier, if they
bought legally produced or counterfeit medicines, or if the
medicines they bought required a prescription (Jackson,
Arver, Banks, & Stecher, 2010; Siva, 2010; Venhuis et al.,
2011). Therefore, the estimated proportion of purchasers who
purchase illicit medicines online should be regarded as a first
indication. An estimated 0.9% of the Dutch population
between ages 19–79 has ever purchased illicit lifestyle drugs
through the surface web. Hereby, sexual enhancers and
weight-loss drugs are the most popular (illicit) lifestyle drugs
purchased online.
Drawing a general profile, purchasers buying (illicit) life-
style drugs and other medicines online are most likely indi-
viduals between the ages of 20 and 40. While there is no
significant gender difference in purchasing medicines online
(men: 50.6%; women: 49.4%), a significant difference can be
found in the types of substances purchased. Men are more
likely to buy painkillers, muscle-enhancing drugs, antiviral
medicines, ADHD medicines, antibiotics, sexual enhancers,
sedatives and tranquillisers, quit-smoking medication and
antidepressants. The only substances that women buy signifi-
cantly more frequently online are weight-loss drugs. The
most popular (illicit) lifestyle drugs purchased by male
respondents are: sexual enhancers and muscle drugs, while
the most popular lifestyle drug purchased online by women
are weight-loss drugs. Indeed, in line with the work of Hall
and Antonopoulos (2016), our data illustrate that the overall
demand for online lifestyle drugs is not gender specific but
that the ‘groups at risk depend more on the specific drug
and the intended purpose’ (p. 77). Importantly, although fur-
ther research should analyse the underlying differences
between men and women in medicines consumption and
online risk taking (Calzo, Sonneville, Scherer, Jackson, &
Austin, 2016), it is important to take gender differences into
account when designing prevention or harm reduction
interventions.
Purchasing lifestyle drugs online
Sexual enhancers and weight-loss drugs are the most popular
(illicit) lifestyle drugs purchased online. Although the results
of the in-depth study are not representative, they provide an
important indication for further research on the demand and
supply of different types of illicit medicines. A key attribute
for respondents to purchase these lifestyle drugs online –
besides financial motivations – is ease or convenience. Similar
results have been found in other prescription/lifestyle drugs
studies (Orsolini, Francesconi, Papanti, Giorgetti, & Schifano,
2015) and some motives, such as convenience, have likewise
been found in other online drugs markets (Barratt et al.,
2014). However, our study also illustrates that it is important
to identify specific motives for online purchasers of different
types of drugs. For example, an important motive for pur-
chasing sexual enhancers online is that buyers do not want
to discuss their use with their doctor (24%) while for
Figure 5. Low to high satisfaction of consumers concerning the quality of and information on online purchased sexual enhancers (n¼ 88) and weight loss drugs
(n¼ 70).
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purchasing weight-loss drugs, the fact that some of these
illicit lifestyle drugs are not available in the Netherlands plays
a role (17%). It is important to take these differences into
consideration when designing and implementing non-judge-
mental prevention campaigns and harm reduction initiatives.
For instance, messages that focus only on the dangers of pur-
chasing poor quality – which currently seems to be the base
of most health messages in relation to the sale of medicine
online – might dissuade some buyers from entering the
online marketplace. However, some buyers want to have the
ability to evaluate quality for themselves and, by and large,
report to be satisfied. Further, since avoidance of embarrass-
ment plays a key role, it could be that this group is currently
willing to take quality risks if this means that they do not
have to disclose their need to a doctor. Future research
should thus differentiate between various types of user
groups and the different reasons for purchasing drugs online
in order to better understand online drug markets.
Although online pharmacies are generally believed to be
the main online source for lifestyle drugs (Di Nicola et al.,
2015; Di Giorgio, 2011; Lavorgna, 2015), we find that other
vending websites, such as second-hand vending sites and
specialist websites attract more than twice as many lifestyle
medicine customers. Moreover, while there are growing con-
cerns that social media may play an active role in the devel-
opment of drug markets, this research indicates that social
media sites and apps are rarely used for buying and selling
lifestyle drugs. Instead, it seems that social media generally
plays a rather indirect role, such as advertising and informa-
tion exchange on consuming lifestyle drugs (Lavorgna, 2015).
In addition, the widespread availability of all sorts of infor-
mation and distribution channels may provide difficulties for
purchasers when determining the legitimacy of online phar-
macies (Di Nicola et al., 2015; Lavorgna, 2015). Unlike the
dark web, purchasers on the surface web cannot make use of
escrow systems that protects them from scamming (Van Hout
& Bingham, 2013). Based on our data, purchasers of lifestyle
drugs on the surface web primarily rely on reviews of others,
as well as on clear information on the medicines and vendor.
However, it should be acknowledged that information on the
medicines and vendors, and reviews on the surface web, do
not guarantee reliable information and quality of substances
(Di Nicola et al., 2015). Nonetheless, most people in this study
who purchase lifestyle drugs online report that they trust the
website they employ. Trust in this context refers to the confi-
dence customers have in these websites and does not neces-
sarily reflect the quality of the purchased illicit drugs. In
online markets, this ‘quality check’ is usually based on having
a reliable friend who has ordered via the same website, ‘trial
and error’ practices, a review by others, and discussing these
online sources on forums and social media platforms
(Kimergård, McVeigh, Knutsson, Breindahl, & Stensballe, 2014;
Van Hout, 2014; Van de Ven, 2015). However, most of these
self-implemented harm-reduction strategies currently used by
users are not evidence based and may not be effective or
even cause greater harm such as testing the product oneself
(the ‘trial and error’ approach) (Kimergård et al., 2014). In
order to reach this group, it is therefore important to imple-
ment harm-reduction strategies, such as testing services and
medical supervision, to promote and protect the health of
lifestyle drug users.
Furthermore, our data show that purchasers are not
always aware of the requirements for purchasing medicines
online. For example, purchasers do not always know whether
or not a prescription is needed and what kinds of websites
are legitimate. Lifestyle drugs can be sold both legally and
illegally on the surface web, which positions it at the intersec-
tion of the legal and illegal online market. It is therefore
important to make (online) customers aware of the potential
risks involved (e.g., contaminated supplements, online scam-
ming), to offer alternatives (e.g. diet and training advice, reli-
able websites) and to protect them against these grey market
issues (e.g. quality labels). However, while informing custom-
ers about counterfeit and poor quality medicines remains
important, it should be acknowledged that many buyers are
actually aware of the risks but still, knowingly, purchase these
substances on the illegal market (Koenraadt, 2012; Van de
Ven & Mulrooney, 2016). Importantly, our data show that the
majority of online purchasers mention that they are very sat-
isfied with the quality of their illicitly purchased lifestyle
drugs and, if they seek more, would return to the same
online supplier. Chaudry and Zimmerman (2009) also note
that there is a common belief that fakes can offer the same
quality of the trademarked product and highlight a lack of
consumer concern for intellectual property rights (IPR).
‘Consumer complicity’ (Hall & Antonopoulos, 2016) seems to
be an important driver for the illicit online market for lifestyle
drugs.
With lifestyle drugs becoming increasingly available online
combined with the high satisfaction rates amongst custom-
ers, it is likely that the online market for lifestyle drugs and
medicines in general will continue to grow. Future research
should monitor the demand and sale of lifestyle drugs as
well as further differentiating between the motives and meth-
ods for purchasing various substances. With more knowledge
about both users and suppliers, as well as about surface web
market dynamics, differentiated prevention, educational cam-
paigns and harm-reduction initiatives can be implemented to
inform online purchasers of lifestyle drugs in a clear and
helpful manner to reduce and prevent (potential) health
harms.
Conclusions
This article has emphasised the role of the Internet in drug
markets and the increased online availability of a broad range
of drugs. There is much intersectionality between different
types of online drug markets, not just in the way drugs are
marketed and sold but also in regard to issues such as quality
and regulatory challenges. Research on online drug markets
often focuses on the distribution of traditional drugs via the
dark web or the selling and buying of NPSs via the surface
web. However, these findings are not necessarily applicable
to online markets for lifestyle drugs. For example, the legal
status of lifestyle drugs differs from that of traditional drugs,
and lifestyle drugs buyers choose the Internet for different
reasons than NPS buyers. In order to deepen our understand-
ing of the demand and supply of a range of new drugs on
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the Internet, while increasingly new types of drugs are
becoming available online, it is important to further monitor
customer preferences and experiences.
Notes
1. The first panel of 56,700 participants was adequate for selecting
447 in-depth study respondents, but, in order to make reliable
estimates on the Dutch population, we rephrased two questions on
off- and online purchasing in a second prevalence study. The
second prevalence study is based on 50,848 respondents, as
outlined in the previous section.
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